Many women suffer from severe chest pain that feels like a heart attack, yet doctors cannot find any blockages in their heart arteries. This confusing condition is called suspected ANOCA or INOCA. For these patients, the pain is real, but standard blockage-clearing surgeries often do not help. This large study looked at whether giving these women a very aggressive medical plan could stop the pain and prevent serious heart events. The researchers wanted to know if pushing harder with medication made a difference for women facing this difficult diagnosis.
The team gathered 2,476 women from 71 different hospitals across the United States. Half of the women received an intensive medical treatment plan, while the other half received usual care. The intensive plan included high doses of statins to lower cholesterol, ACE inhibitors or ARBs to manage blood pressure, and aspirin to prevent clots. The usual care group received the standard medications doctors typically prescribe for heart health. Both groups also received advice on lifestyle changes like diet and exercise.
The women followed this plan for two and a half years. The main goal was to see if the intensive group had fewer major heart events, such as death, heart attack, stroke, or hospital stays for heart failure. The study found no difference between the two groups. In the intensive group, 221 women had a major event. In the usual care group, 200 women had a major event. The numbers were very close, showing that the extra medications did not provide extra protection.
Safety was also checked during the study. The report did not list any specific side effects or reasons why patients stopped taking their medicines. Because the study did not find a difference in outcomes, there were no safety concerns raised about the intensive treatment plan itself. The medications used are common and generally well-tolerated, but this study did not report specific issues like muscle pain or low blood pressure that might occur with high doses.
It is important not to jump to conclusions based on this single study. The researchers admitted that fewer women joined the study than they had planned, which makes the results less certain. The group was also older, with an average age of 64, and their blood pressure and cholesterol were already well-controlled before the study started. Because of these factors, the study did not have enough power to prove that the intensive treatment is definitely not helpful. It simply showed that it did not help in this specific group.
For patients right now, this study means that doctors should not stop using standard heart medications just because of these results. However, it also suggests that we cannot assume that a more aggressive approach will automatically work for everyone with this condition. More investigation is needed to find the best way to help women with suspected ANOCA or INOCA who suffer from a high burden of hospital visits and poor quality of life. Until more evidence is available, the best approach remains a careful balance of proven treatments and individual patient needs.
